Related Experiment Video
Updated: Dec 23, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Berberine Suppressed Tumor Growth through Regulating Fatty Acid Metabolism and Triggering Cell Apoptosis via
Lingli Li1, Ze Peng1, Qian Hu1,2
1Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
Aim:
To further investigate the mechanism behind the antitumor properties of berberine regarding lipid metabolism.
Methods:
Cell viability, proliferation, and apoptosis assays were performed to determine the antigrowth effects of berberine in vitro. Ectopic xenograft models in Balb/c nude mice were established to determine the antitumor effects of berberine in vivo.
Results:
Berberine inhibited cell viability and proliferation of MGC803 human gastric cancer cell lines in a time- and dose-dependent manner. Berberine induced apoptosis of MGC803 and increased the apoptotic rate with higher doses. Berberine induced the accumulation of fatty acid of MGC803 and suppressed the protein expression of FABPs and PPARα. The FABP inhibitor BMS309403 recapitulated the effects of berberine on MGC803 cells. In the xenograft model, berberine significantly decreased the tumor volume and tumor weight and induced apoptosis in tumor tissues. Berberine significantly elevated the fatty acid content and inhibited the expression of FABPs and PPARα in the MGC803 xenograft models.
Conclusion:
Berberine exerted anticancer effects on human gastric cancer both in vitro and in vivo by inducing apoptosis, which was due to the reduced protein expression of FABPs and the accumulation of fatty acid.
Insights
Berberine demonstrates anticancer effects against human gastric cancer by inducing apoptosis. This occurs through reduced fatty acid-binding protein (FABP) expression and increased fatty acid accumulation, impacting lipid metabolism.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Gastric cancer remains a significant global health challenge.
- Berberine, a natural compound, has shown potential anticancer properties.
- Understanding berberine's mechanism, particularly its role in lipid metabolism, is crucial for therapeutic development.
Purpose of the Study:
- To investigate the antitumor mechanism of berberine in human gastric cancer.
- To explore the role of lipid metabolism in berberine's anticancer effects.
- To determine the impact of berberine on fatty acid-binding proteins (FABPs) and PPARα.
Main Methods:
- In vitro assays: cell viability, proliferation, and apoptosis assays using MGC803 cells.
- In vivo studies: ectopic xenograft models in Balb/c nude mice.
- Biochemical analysis: assessment of fatty acid accumulation and FABP/PPARα protein expression.
Main Results:
- Berberine inhibited MGC803 cell viability and proliferation in a dose- and time-dependent manner.
- Berberine induced apoptosis in MGC803 cells and reduced tumor volume/weight in vivo.
- Berberine led to fatty acid accumulation and suppressed FABP/PPARα expression, effects mimicked by a FABP inhibitor.
Conclusions:
- Berberine exhibits significant anticancer effects against human gastric cancer both in vitro and in vivo.
- The antitumor activity is mediated by berberine-induced apoptosis.
- This apoptosis is linked to reduced FABP expression and consequent fatty acid accumulation, highlighting berberine's impact on lipid metabolism.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

